GGrantIndex
Sort

46,585 grants matching heart failure

Elucidating Electro-Mechanical Dysfunction in Heart Failure with Human Stem Cell Models

$2,366,100
Joseph C Wu · Stanford University · P01 · FY2021 · HL

Dysfunctional regeneration in cardiomyopathy: iPS-based diagnosis and therapy

$2,365,500
Timothy James Nelson · Mayo Clinic Rochester · DP2 · FY2010 · OD

Cardiac Gene Transfer of AC & Mechanisms for Effects

$2,364,337
H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2010 · HL

Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy

$2,356,223
Jeffrey A Towbin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · HL

Immunophenotyping of Human Hypertension Using Single Cell Multiplex Mass Cytometry to Identify Novel Therapeutic Targets

$2,355,000
Meenakshi Swaminathan Madhur · Vanderbilt University Medical Center · DP2 · FY2016 · HL

Elucidating Cell Communication Networks during Tissue Inflammation, Fibrosis, and Regeneration

$2,355,000
Kevin R King · University Of California, San Diego · DP2 · FY2018 · AR

Resolving Incomplete Penetrance in the Cardiomyopathies and Channelopathies

$2,355,000
Rahul Chandrakant Deo · University Of California, San Francisco · DP2 · FY2013 · HL

Mitigating Diabetic Ketoacidosis in People with T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation into an Enhanced Glucose Ketone Report

$2,352,906
Richard Mauritz Bergenstal · Healthpartners Institute · U01 · FY2025 · DK

Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study)

$2,352,905
Alan Thevenet N. Tita · University Of Alabama At Birmingham · R01 · FY2021 · HL

Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy

$2,350,202
Jeffrey A Towbin · Cincinnati Childrens Hosp Med Ctr · R01 · FY2015 · HL

Improving Diagnostic Accuracy for Acute Heart Failure

$2,349,037
Deepak Gupta · Vanderbilt University Medical Center · R01 · FY2021 · HL

Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease

$2,348,967
Henry M Colecraft · Columbia University Health Sciences · P01 · FY2024 · HL

COBRE-DIABETES

$2,347,500
Mariana Gerschenson · University Of Hawaii At Manoa · P20 · FY2024 · GM

COBRE-DIABETES

$2,347,500
Mariana Gerschenson · University Of Hawaii At Manoa · P20 · FY2025 · GM

Center of Biomedical Research Excellence in Cardiovascular Health

$2,347,347
David G Edwards · University Of Delaware · P20 · FY2022 · GM

Pharmacogenomic Evaluation of Antihypertensive Responses

$2,346,440
Julie A. Johnson · University Of Florida · U01 · FY2009 · GM

"Novel Mechanisms for Cardiac Injury and Repair"

$2,345,340
Walter J Koch · Thomas Jefferson University · P01 · FY2008 · HL

Pharmacogenomic Evaluation of Antihypertensive Responses

$2,344,064
Julie A. Johnson · University Of Florida · U01 · FY2008 · GM

CaMKII and InsP3-Mediated Signaling in Cardiac Myocytes

$2,342,204
Donald M Bers · University Of California At Davis · P01 · FY2014 · HL

1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis

$2,341,858
Michael J Boeckh · Fred Hutchinson Cancer Research Center · UG3 · FY2020 · HL

Center of Biomedical Research Excellence in Cardiovascular Health

$2,339,997
David G Edwards · University Of Delaware · P20 · FY2020 · GM

Center of Biomedical Research Excellence in Cardiovascular Health

$2,339,997
David G Edwards · University Of Delaware · P20 · FY2019 · GM

Cavopulmonary Assist to Reverse the Fontan

$2,339,842
Mark D Rodefeld · Indiana University Indianapolis · R01 · FY2022 · HL

The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury

$2,339,338
Dolly Mehta · University Of Illinois At Chicago · P01 · FY2022 · HL

The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury

$2,339,337
Dolly Mehta · University Of Illinois At Chicago · P01 · FY2025 · HL